AI assistant
BALCHEM CORP — Director's Dealing 2012
Mar 1, 2012
31041_dirs_2012-03-01_631f494d-013b-4265-926a-742af46a6b7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2012-02-28
Reporting Person: Houston Matthew David (General Counsel/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-28 | Common Stock | A | 1867 | — | Acquired | 10739 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-28 | Employee Stock Option (right to buy) | $29.06 | A | 5835 | Acquired | 2022-02-28 | Common Stock (0) | Direct |
Footnotes
F1: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: This filing amends the "Amount of Securities Beneficially Owned Following Reported Transaction" to include the most current amount of shares owned directly by Mr. Houston in his 401(k)/profit sharing account.
F3: Options vest 20% year 1; 40% year 2; and 40% year 3